Consultation with your healthcare provider before stopping is essential to assess the reasons for discontinuation, evaluate potential consequences, and develop an appropriate transition plan
"GLP-1 Weight Loss Drugs: Coverage Under Medicaid and Other Health Plans." Analysis showing 9 states cover GLP-1s for obesity under Medicaid as of March 2025
Over 12 months, 87.8% of participants taking tirzepatide lost 5% or more of their starting weight vs
We also provide injectable wrinkle relaxers and fillers, laser skin resurfacing, micro-needling, chemical peels and other treatments to complement your hormone therapy
Clinical trial data does not show a direct causal link, but FDA post-market surveillance and real-world reports document depression in some users
Wood reports grants from Beef Checkoff (payments made to institution) and Hass Avocado Board (payments made to institution)